Ki Hyeong Lee

Researcher Next ID · RN-005699

Researcher · Medicine

Cheongju-si, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

HER2/EGFR in Cancer Research

Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1913662
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1810865
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1713137
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709937
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.44.2806

No projects listed.